retatrutide safety study Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio Efficacy and safety of retatrutide,

The reduced food drive creates space for developing new coping strategies and addressing root causes of emotional eating

After lunch, nutrition whiz Christine Craig, MS, RDN, CDCES expertly details the latest in MNT and provides real strategies on translating this content to your clinical practice

Chng mt, ngt xu

Ask your doctor which medication has the best formulary placement on your specific plan

The review notes, however, that the degree to which these benefits are independent of weight loss may vary by condition, and further research is needed to elucidate these mechanisms fully

"And certainly if they're going to be starting a GLP-1, it's always safer to have an exam prior to and shortly after starting treatment if there's any changes in the vision." For people worried about potential vision complications or wondering if a GLP-1 can cause blindness, Dr